{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:06:33Z","timestamp":1788393993701,"version":"build-2803163510"},"reference-count":23,"publisher":"Japanese Society of Veterinary Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.24-0405","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T22:10:56Z","timestamp":1740348656000},"page":"426-430","source":"Crossref","is-referenced-by-count":2,"title":["&lt;i&gt;In vitro&lt;\/i&gt; susceptibility of differentiated SH-SY5Y human          neuroblastoma cells to herpes simplex virus type 1 and Japanese encephalitis virus          infection"],"prefix":"10.1292","volume":"87","author":[{"given":"Jannatul","family":"FERDOUS","sequence":"first","affiliation":[{"name":"Department of Basic Veterinary Science, Joint Faculty of Veterinary              Medicine, Kagoshima University, Kagoshima, Japan"},{"name":"Department of Pharmacology, Faculty of Veterinary Science, Bangladesh              Agricultural University, Mymensingh, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"MAKINO","sequence":"additional","affiliation":[{"name":"Department of Basic Veterinary Science, Joint Faculty of Veterinary              Medicine, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"MASATANI","sequence":"additional","affiliation":[{"name":"Joint Graduate School of Veterinary Sciences, Gifu University, Gifu,              Japan"},{"name":"Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences,              Gifu University, Gifu, Japan"},{"name":"Center for One Medicine Innovative Translational Research (COMIT), Gifu              University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"FUJIMOTO","sequence":"additional","affiliation":[{"name":"Transboundary Animal Diseases Research Center, Joint Faculty of Veterinary              Medicine, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotada","family":"NAITOU","sequence":"additional","affiliation":[{"name":"Department of Basic Veterinary Science, Joint Faculty of Veterinary              Medicine, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuya","family":"SHIRAISHI","sequence":"additional","affiliation":[{"name":"Department of Basic Veterinary Science, Joint Faculty of Veterinary              Medicine, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","unstructured":"1. Biedler              JL,                Roffler-Tarlov              S, Schachner              M, Freedman              LS. 1978.            Multiple neurotransmitter synthesis by human neuroblastoma cell lines and            clones. <i>Cancer Res<\/i>          38: 3751\u20133757."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bohmwald              K, Andrade              CA, G\u00e1lvez              NMS, Mora              VP, Mu\u00f1oz              JT, Kalergis              AM. 2021.            The causes and long-term consequences of viral            encephalitis. <i>Front Cell Neurosci<\/i>          15: 755875.","DOI":"10.3389\/fncel.2021.755875"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Christensen              J, Steain              M, Slobedman              B, Abendroth              A. 2011.            Differentiated neuroblastoma cells provide a highly efficient model for            studies of productive varicella-zoster virus infection of neuronal          cells. <i>J Virol<\/i>          85: 8436\u20138442.","DOI":"10.1128\/JVI.00515-11"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Griffiths              MJ, Turtle              L, Solomon              T. 2014.            Japanese encephalitis virus infection.              <i>Handb Clin Neurol<\/i>          123: 561\u2013576.","DOI":"10.1016\/B978-0-444-53488-0.00026-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hegde              NR, Gore              MM. 2017.            Japanese encephalitis vaccines: Immunogenicity, protective efficacy,            effectiveness, and impact on the burden of disease. <i>Hum              Vaccin Immunother<\/i>          13: 1\u201318.","DOI":"10.1080\/21645515.2017.1285472"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. James              C, Harfouche              M, Welton              NJ, Turner              KM,                Abu-Raddad              LJ, Gottlieb              SL, Looker              KJ. 2020.            Herpes simplex virus: global infection prevalence and incidence            estimates, 2016. <i>Bull World Health            Organ<\/i>          98: 315\u2013329.","DOI":"10.2471\/BLT.19.237149"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Joe              S, Salam              AAA, Neogi              U, N              NB, Mudgal              PP. 2022.            Antiviral drug research for Japanese encephalitis: an updated            review. <i>Pharmacol Rep<\/i>          74: 273\u2013296.","DOI":"10.1007\/s43440-022-00355-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kimura              T, Okumura              M, Kim              E, Sasaki              M, Orba              Y, Sawa              H. 2013.            Characterization of Japanese encephalitis virus infection in an            immortalized mesencephalic cell line, CSM14.1. <i>Microbiol              Immunol<\/i>          57: 723\u2013731.","DOI":"10.1111\/1348-0421.12085"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kovalevich              J, Langford              D. 2013.            Considerations for the use of SH-SY5Y neuroblastoma cells in            neurobiology. <i>Methods Mol Biol<\/i>          1078: 9\u201321.","DOI":"10.1007\/978-1-62703-640-5_2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lopez-Suarez              L, Awabdh              SA, Coumoul              X, Chauvet              C. 2022.            The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model            for investigating neurotoxicology in human: Focus on organic pollutants.              <i>Neurotoxicology<\/i>          92: 131\u2013155.","DOI":"10.1016\/j.neuro.2022.07.008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Maldonado              H,                Ortiz-Ria\u00f1o              E, Krause              B, Barriga              A, Medina              F, Pando              ME, Alberti              C, Kettlun              AM, Collados              L, Garc\u00eda              L, Cartier              L, Valenzuela              MA. 2008.            Microtubule proteins and their post-translational forms in the            cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in            SH-SY5Y cells: an in vitro model of HTLV-I-induced disease.              <i>Biol Res<\/i>          41: 239\u2013259.","DOI":"10.4067\/S0716-97602008000300001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Noh              SS, Shin              HJ. 2023.            Role of virus-induced EGFR trafficking in proviral            functions. <i>Biomolecules<\/i>          13: 1766.","DOI":"10.3390\/biom13121766"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Peng              Y, Chu              S, Yang              Y, Zhang              Z, Pang              Z, Chen              N. 2021.            Neuroinflammatory in vitro cell culture models and the potential            applications for neurological disorders. <i>Front              Pharmacol<\/i>          12: 671734.","DOI":"10.3389\/fphar.2021.671734"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shimoda              H, Mahmoud              HY, Noguchi              K, Terada              Y, Takasaki              T, Shimojima              M, Maeda              K. 2013.            Production and characterization of monoclonal antibodies to Japanese            encephalitis virus. <i>J Vet Med Sci<\/i>          75: 1077\u20131080.","DOI":"10.1292\/jvms.12-0558"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shipley              MM, Mangold              CA, Szpara              ML. 2016.            Differentiation of the SH-SY5Y human neuroblastoma Cell            Line. <i>J Vis Exp<\/i>          108: 53193.","DOI":"10.3791\/53193"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shipley              MM, Mangold              CA, Kuny              CV, Szpara              ML. 2017.            Differentiated human SH-SY5Y cells provide a reductionist model of herpes            simplex virus 1 neurotropism. <i>J Virol<\/i>          91: e00958\u2013e17.","DOI":"10.1128\/JVI.00958-17"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Solomon              T. 2006.            Control of Japanese encephalitis-within our              grasp?<i>N Engl J Med<\/i>          355: 869\u2013871.","DOI":"10.1056\/NEJMp058263"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Whitley              RJ, Soong              SJ, Dolin              R, Galasso              GJ, Ch\u2019ien              LT, Alford              CA. 1977.            Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis.            National Institute of Allergy and Infectious Diseases collaborative antiviral            study. <i>N Engl J Med<\/i>          297: 289\u2013294.","DOI":"10.1056\/NEJM197708112970601"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wongchitrat              P, Samutpong              A, Lerdsamran              H,                Prasertsopon              J, Yasawong              M,                Govitrapong              P,                Puthavathana              P, Kitidee              K. 2019.            Elevation of cleaved p18 Bax levels associated with the kinetics of            neuronal cell death during Japanese encephalitis virus infection.              <i>Int J Mol Sci<\/i>          20: 5016.","DOI":"10.3390\/ijms20205016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Xu              Q, Cao              M, Song              H, Chen              S, Qian              X, Zhao              P, Ren              H, Tang              H, Wang              Y, Wei              Y, Zhu              Y, Qi              Z. 2016.            Caveolin-1-mediated Japanese encephalitis virus entry requires a two-step            regulation of actin reorganization. <i>Future              Microbiol<\/i>          11: 1227\u20131248.","DOI":"10.2217\/fmb-2016-0002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yadav              P,                Chakraborty              P, Jha              NK, Dewanjee              S, Jha              AK, Panda              SP, Mishra              PC, Dey              A, Jha              SK. 2022.            Molecular mechanism and role of Japanese encephalitis virus infection in            central nervous system-mediated diseases.              <i>Viruses<\/i>          14: 2686.","DOI":"10.3390\/v14122686"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zheng              K, Kitazato              K, Wang              Y. 2014.            Viruses exploit the function of epidermal growth factor            receptor. <i>Rev Med Virol<\/i>          24: 274\u2013286.","DOI":"10.1002\/rmv.1796"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zhu              Y, He              Z, Qi              Z. 2023.            Virus-host interactions in early Japanese encephalitis virus            infection. <i>Virus Res<\/i>          331: 199120.","DOI":"10.1016\/j.virusres.2023.199120"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/4\/87_24-0405\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:28:49Z","timestamp":1746847729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/4\/87_24-0405\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.24-0405","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-0405"}}